U.S. payers to incorporate biogeneric agents into their formularies
Decision Resources, a leading research and advisory firm for pharmaceutical and healthcare issues, is reporting that U.S. payers expect to incorporate biogeneric agents into their formularies quite rapidly. According to the new special report entitled "Biogenerics 2007-2016: Physician and Payer Acceptance Fuels Brand Erosion," about 60% of pharmacy directors expect to reimburse biogenerics within a drug's first six months on the market, and nearly 100% of 40 surveyed payers will include these agents on their formularies within the first year.
Click here to see more articles from Drug Topics Daily News.
To go to the Drug Topics homepage, click here.